Literature DB >> 29776614

Characterisation of peripheral blood mononuclear cell populations in periparturient dairy cows that develop metritis.

John J Bromfield1, Meghan M Watt2, Sossi M Iacovides2.   

Abstract

Bacterial contamination of the uterus following calving is ubiquitous in the dairy cow, 40% of cows develop postpartum uterine infection, including metritis. While predisposing factors like twinning and dystocia are associated with metritis, it is unclear why some cows remain healthy following calving and others develop uterine infection, negatively impacting animal health, milk production and economic return. Here, we profiled peripheral blood mononuclear cells of cows before calving and during postpartum metritis. We hypothesized that peripheral blood mononuclear cell function and proportions would be altered during the prepartum period in cows that develop postpartum metritis. Using flow cytometry we observed reduced proportions of peripheral CD3+/CD4+, CD4+/CD62L+, FOXP3+ and CD21+ populations from -10 to 40 days relative to calving associated with metritis, while the proportion of peripheral CD3+/CD4+ lymphocytes were specifically reduced in the prepartum period before the onset of metritis. Peripheral blood mononuclear cells from cows with metritis had a perturbed capacity to secrete IL-1β or IFNγ in response to in vitro stimulus; cells collected during the prepartum period from cows that would go on to develop metritis failed to increase IL-1β secretion in response to stimulation, while IFNγ secretion was altered at calving and postpartum in cows with metritis compared to healthy herd mates. No effect of metritis was observed in the capacity of cows to mount a humoral immune response to antigen administered on the day of calving. The studies discussed here suggest that while minor changes to the prepartum immune system are observed in cows that develop metritis, changes observed in the postpartum period are more prevalent and likely a consequences of disease and not causative. Future studies to modulate the prepartum immune system may help to limit postpartum metritis.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immune system; Metritis; Periparturient; Prepartum; Uterine disease

Mesh:

Substances:

Year:  2018        PMID: 29776614      PMCID: PMC6445263          DOI: 10.1016/j.vetimm.2018.04.010

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  43 in total

1.  Influence of uterine bacterial contamination after parturition on ovarian dominant follicle selection and follicle growth and function in cattle.

Authors:  I M Sheldon; D E Noakes; A N Rycroft; D U Pfeiffer; H Dobson
Journal:  Reproduction       Date:  2002-06       Impact factor: 3.906

2.  Defining and diagnosing postpartum clinical endometritis and its impact on reproductive performance in dairy cows.

Authors:  S J LeBlanc; T F Duffield; K E Leslie; K G Bateman; G P Keefe; J S Walton; W H Johnson
Journal:  J Dairy Sci       Date:  2002-09       Impact factor: 4.034

3.  Relationship between intra-uterine bacterial contamination, endotoxin levels and the development of endometritis in postpartum cows with dystocia or retained placenta.

Authors:  M J Dohmen; K Joop; A Sturk; P E Bols; J A Lohuis
Journal:  Theriogenology       Date:  2000-10-15       Impact factor: 2.740

4.  Evaluation of a systemic antibiotic treatment of toxic puerperal metritis in dairy cows.

Authors:  M Drillich; O Beetz; A Pfützner; M Sabin; H J Sabin; P Kutzer; H Nattermann; W Heuwieser
Journal:  J Dairy Sci       Date:  2001-09       Impact factor: 4.034

Review 5.  Micronutrients and immune function in cattle.

Authors:  J W Spears
Journal:  Proc Nutr Soc       Date:  2000-11       Impact factor: 6.297

6.  Chemiluminescence of bovine polymorphonuclear leucocytes during the periparturient period and relation with metabolic markers and bovine pregnancy-associated glycoprotein.

Authors:  D Hoeben; E Monfardini; G Opsomer; C Burvenich; H Dosogne; A De Kruif; J F Beckers
Journal:  J Dairy Res       Date:  2000-05       Impact factor: 1.904

7.  Uterine involution and fertility of holstein cows subsequent to early postpartum PGF2alpha treatment for acute puerperal metritis.

Authors:  P Melendez; J McHale; J Bartolome; L F Archbald; G A Donovan
Journal:  J Dairy Sci       Date:  2004-10       Impact factor: 4.034

8.  Risk factors for metritis in Danish dairy cows.

Authors:  J Bruun; A K Ersbøll; L Alban
Journal:  Prev Vet Med       Date:  2002-06-25       Impact factor: 2.670

9.  Effects of the mammary gland on functional capacities of blood mononuclear leukocyte populations from periparturient cows.

Authors:  B J Nonnecke; K Kimura; J P Goff; M E Kehrli
Journal:  J Dairy Sci       Date:  2003-07       Impact factor: 4.034

10.  Studies on susceptibility to infection following ionizing radiation. V. Comparison of intraperitoneal and intravenous challenge at intervals following different doses of x-radiation.

Authors:  C P MILLER; C W HAMMOND; S K ANDERLE
Journal:  J Exp Med       Date:  1960-06-01       Impact factor: 14.307

View more
  3 in total

1.  Persistent effects on bovine granulosa cell transcriptome after resolution of uterine disease.

Authors:  Rachel L Piersanti; Anthony D Horlock; Jeremy Block; José E P Santos; I Martin Sheldon; John J Bromfield
Journal:  Reproduction       Date:  2019-07       Impact factor: 3.906

2.  Indicators of immunosuppression peripartum in dual purpose cows in the tropics affected health, productive and reproductive parameters.

Authors:  Miguel Ángel Lammoglia; Ivan Avalos; Amalia Cabrera; Maria Rebeca Rojas; Nora Garcez; Abigail Tabarez
Journal:  Anim Reprod       Date:  2022-01-07       Impact factor: 1.807

3.  A Fixed Cohort Field Study of Gene Expression in Circulating Leukocytes From Dairy Cows With and Without Mastitis.

Authors:  Craig S McConnel; Sierra A Crisp; Tyler D Biggs; Stephen P Ficklin; Lindsay M Parrish; Sophie C Trombetta; William M Sischo; Amber Adams-Progar
Journal:  Front Vet Sci       Date:  2020-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.